Impact of developmental exposure to methylphenidate on rat brain’s immune privilege and behavior: Control versus ADHD model
Autor: | Vanessa Coelho-Santos, Filipa L. Cardoso, Carlos Fontes-Ribeiro, Ricardo A. Leitão, Ana P. Silva |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Immunology Prefrontal Cortex Anxiety Immune Privilege Blood–brain barrier medicine.disease_cause Rats Inbred WKY 03 medical and health sciences Behavioral Neuroscience 0302 clinical medicine Immune system Immune privilege Rats Inbred SHR Internal medicine mental disorders medicine Animals Attention deficit hyperactivity disorder Attention Prefrontal cortex Neuroinflammation Endocrine and Autonomic Systems Methylphenidate Brain medicine.disease Rats Disease Models Animal 030104 developmental biology medicine.anatomical_structure Endocrinology Attention Deficit Disorder with Hyperactivity Blood-Brain Barrier Exploratory Behavior Central Nervous System Stimulants Psychology human activities Neuroscience 030217 neurology & neurosurgery Oxidative stress medicine.drug |
Zdroj: | Brain, Behavior, and Immunity. 68:169-182 |
ISSN: | 0889-1591 |
Popis: | Attention deficit hyperactivity disorder (ADHD) is the most prevalent childhood mental disorders that often persists into adulthood. Moreover, methylphenidate (MPH) is the mainstay of medical treatment for this disorder. Yet, not much is known about the neurobiological impact of MPH on control versus ADHD conditions, which is crucial to simultaneously clarify the misuse/abuse versus therapeutic use of this psychostimulant. In the present study, we applied biochemical and behavioral approaches to broadly explore the early-life chronic exposure of two different doses of MPH (1.5 and 5 mg/kg/day) on control and ADHD rats (Wistar Kyoto and Spontaneously Hypertensive rats, respectively). We concluded that the higher dose of MPH promoted blood-brain barrier (BBB) permeability and elicited anxiety-like behavior in both control and ADHD animals. BBB dysfunction triggered by MPH was particularly prominent in control rats, which was characterized by a marked disruption of intercellular junctions, an increase of endothelial vesicles, and an upregulation of adhesion molecules concomitantly with the infiltration of peripheral immune cells into the prefrontal cortex. Moreover, both doses of MPH induced a robust neuroinflammatory and oxidative response in control rats. Curiously, in the ADHD model, the lower dose of MPH (1.5 mg/kg/day) had a beneficial effect since it balanced both immunity and behavior relative to vehicle animals. Overall, the contrasting effects of MPH observed between control and ADHD models support the importance of an appropriate MPH dose regimen for ADHD, and also suggest that MPH misuse negatively affects brain and behavior. |
Databáze: | OpenAIRE |
Externí odkaz: |